As manager of Pew's drug safety project, Cosel works on federal initiatives to ensure the safety and oversight of the U.S. pharmaceutical supply chain. Prior to joining Pew, Cosel worked on issues of pharmaceutical safety and appropriate prescribing for national advocacy Organization Community Catalyst, and in grassroots development and capacity-building with the Fund for Public Interest Research in Cambridge, Massachusetts.
Cosel received her M.Sc. in human rights from the London School of Economics and a BA from Yale University.
Recent WorkView All
Fourteen people—including former pharmacists, pharmacy technicians, and the owners of the New England Compounding Center in Framingham, Massachusetts—were charged Dec. 17 for their alleged roles in a 2012 outbreak of spinal meningitis that sickened more than 750 people and killed 64. Contamination of compounded steroid injections led to a recall of all the company’s products in... Read More
While the threat of antibiotic resistance is growing, regulatory approval for drugs to treat highly resistant bacterial infections can be challenging. Only a small number of patients who contract such infections meet the requirements to participate in traditional clinical trials. It’s difficult for researchers to select and enroll subjects in clinical trials to study treatments for some of... Read More
On Dec. 10, 2014, Senators Michael Bennet (D-CO) and Orrin Hatch (R-UT) introduced a bill to promote the development of much-needed antibiotics. Read More